
Deirdre Renee Claytor
Supervisory Patent Examiner (ID: 11299, Phone: (571)272-8394 , Office: P/1651 )
| Most Active Art Unit | 1627 |
| Art Unit(s) | 1651, 1617, 1627, 1691 |
| Total Applications | 768 |
| Issued Applications | 255 |
| Pending Applications | 51 |
| Abandoned Applications | 465 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5068980
[patent_doc_number] => 20070190081
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-16
[patent_title] => 'Aqueous suspension for nasal drops'
[patent_app_type] => utility
[patent_app_number] => 11/245252
[patent_app_country] => US
[patent_app_date] => 2005-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4496
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0190/20070190081.pdf
[firstpage_image] =>[orig_patent_app_number] => 11245252
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/245252 | Aqueous suspension for nasal drops | Oct 6, 2005 | Abandoned |
Array
(
[id] => 5880544
[patent_doc_number] => 20060029626
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-09
[patent_title] => 'Cosmetic composition'
[patent_app_type] => utility
[patent_app_number] => 11/244001
[patent_app_country] => US
[patent_app_date] => 2005-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6414
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0029/20060029626.pdf
[firstpage_image] =>[orig_patent_app_number] => 11244001
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/244001 | Cosmetic composition | Oct 5, 2005 | Issued |
Array
(
[id] => 5638186
[patent_doc_number] => 20060069160
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-30
[patent_title] => 'Composition for treating bacterial, viral, fungal diseases, inflammation and pain'
[patent_app_type] => utility
[patent_app_number] => 11/234874
[patent_app_country] => US
[patent_app_date] => 2005-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2782
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0069/20060069160.pdf
[firstpage_image] =>[orig_patent_app_number] => 11234874
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/234874 | Composition for treating bacterial, viral, fungal diseases, inflammation and pain | Sep 22, 2005 | Issued |
Array
(
[id] => 6375219
[patent_doc_number] => 20100075992
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-25
[patent_title] => 'Tetrodotoxin and its derivatives for the treament of peripheral-nervously derived neuropathi pain'
[patent_app_type] => utility
[patent_app_number] => 11/663358
[patent_app_country] => US
[patent_app_date] => 2005-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4134
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0075/20100075992.pdf
[firstpage_image] =>[orig_patent_app_number] => 11663358
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/663358 | Tetrodotoxin and its derivatives for the treament of peripheral-nervously derived neuropathi pain | Sep 19, 2005 | Abandoned |
Array
(
[id] => 5705825
[patent_doc_number] => 20060194873
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-31
[patent_title] => 'Methods of treating epileptogenesis and epilepsy'
[patent_app_type] => utility
[patent_app_number] => 11/227247
[patent_app_country] => US
[patent_app_date] => 2005-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 29105
[patent_no_of_claims] => 87
[patent_no_of_ind_claims] => 42
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0194/20060194873.pdf
[firstpage_image] =>[orig_patent_app_number] => 11227247
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/227247 | Methods of treating epileptogenesis and epilepsy | Sep 14, 2005 | Abandoned |
Array
(
[id] => 204892
[patent_doc_number] => 07629382
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-12-08
[patent_title] => 'Use of tellurium containing compounds as nerve protecting agents'
[patent_app_type] => utility
[patent_app_number] => 11/226374
[patent_app_country] => US
[patent_app_date] => 2005-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 13612
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/629/07629382.pdf
[firstpage_image] =>[orig_patent_app_number] => 11226374
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/226374 | Use of tellurium containing compounds as nerve protecting agents | Sep 14, 2005 | Issued |
Array
(
[id] => 5777362
[patent_doc_number] => 20060106002
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-18
[patent_title] => 'Therapeutic agent for steroid depending-and/or steroid resistant- ulcerative colitis'
[patent_app_type] => utility
[patent_app_number] => 11/225047
[patent_app_country] => US
[patent_app_date] => 2005-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3917
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0106/20060106002.pdf
[firstpage_image] =>[orig_patent_app_number] => 11225047
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/225047 | Therapeutic agent for steroid depending-and/or steroid resistant- ulcerative colitis | Sep 13, 2005 | Abandoned |
Array
(
[id] => 122126
[patent_doc_number] => 07704522
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-04-27
[patent_title] => 'Topical medicament'
[patent_app_type] => utility
[patent_app_number] => 11/220138
[patent_app_country] => US
[patent_app_date] => 2005-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4581
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/704/07704522.pdf
[firstpage_image] =>[orig_patent_app_number] => 11220138
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/220138 | Topical medicament | Sep 5, 2005 | Issued |
Array
(
[id] => 5148174
[patent_doc_number] => 20070048230
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-01
[patent_title] => 'Pheromone compositions and methods'
[patent_app_type] => utility
[patent_app_number] => 11/211227
[patent_app_country] => US
[patent_app_date] => 2005-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2948
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20070048230.pdf
[firstpage_image] =>[orig_patent_app_number] => 11211227
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/211227 | Pheromone compositions and methods | Aug 23, 2005 | Abandoned |
Array
(
[id] => 4999290
[patent_doc_number] => 20070041924
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-22
[patent_title] => 'Sebum Control Compositions Based on Saponins and Sapogenins'
[patent_app_type] => utility
[patent_app_number] => 11/161856
[patent_app_country] => US
[patent_app_date] => 2005-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 12008
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0041/20070041924.pdf
[firstpage_image] =>[orig_patent_app_number] => 11161856
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/161856 | Sebum Control Compositions Based on Saponins and Sapogenins | Aug 18, 2005 | Abandoned |
Array
(
[id] => 5801425
[patent_doc_number] => 20060035889
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-16
[patent_title] => 'Treatment for methamphetamine addiction and reduction of methamphetamine use using serotonin antagonists'
[patent_app_type] => utility
[patent_app_number] => 11/205769
[patent_app_country] => US
[patent_app_date] => 2005-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 14221
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20060035889.pdf
[firstpage_image] =>[orig_patent_app_number] => 11205769
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/205769 | Treatment for methamphetamine addiction and reduction of methamphetamine use using serotonin antagonists | Aug 14, 2005 | Abandoned |
Array
(
[id] => 161748
[patent_doc_number] => 07670619
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-03-02
[patent_title] => 'Controlled-release formulations containing tryptophan or its metabolites'
[patent_app_type] => utility
[patent_app_number] => 11/201070
[patent_app_country] => US
[patent_app_date] => 2005-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3394
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/670/07670619.pdf
[firstpage_image] =>[orig_patent_app_number] => 11201070
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/201070 | Controlled-release formulations containing tryptophan or its metabolites | Aug 8, 2005 | Issued |
Array
(
[id] => 5801639
[patent_doc_number] => 20060035974
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-16
[patent_title] => 'Linoleic acid active agents for enhancing probability of becoming pregnant'
[patent_app_type] => utility
[patent_app_number] => 11/198003
[patent_app_country] => US
[patent_app_date] => 2005-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7647
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20060035974.pdf
[firstpage_image] =>[orig_patent_app_number] => 11198003
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/198003 | Linoleic acid active agents for enhancing probability of becoming pregnant | Aug 4, 2005 | Issued |
Array
(
[id] => 10838076
[patent_doc_number] => 08865749
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-10-21
[patent_title] => 'Treatment and prevention of Th1 and ‘autoimmune’ diseases effected with antibiotics and/or angiotensin inhibition'
[patent_app_type] => utility
[patent_app_number] => 11/161318
[patent_app_country] => US
[patent_app_date] => 2005-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3516
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 132
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11161318
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/161318 | Treatment and prevention of Th1 and ‘autoimmune’ diseases effected with antibiotics and/or angiotensin inhibition | Jul 28, 2005 | Issued |
Array
(
[id] => 5819926
[patent_doc_number] => 20060024239
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-02
[patent_title] => 'Persistent post-viral cough drug and treatment method'
[patent_app_type] => utility
[patent_app_number] => 11/190335
[patent_app_country] => US
[patent_app_date] => 2005-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3443
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0024/20060024239.pdf
[firstpage_image] =>[orig_patent_app_number] => 11190335
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/190335 | Persistent post-viral cough drug and treatment method | Jul 26, 2005 | Abandoned |
Array
(
[id] => 5873223
[patent_doc_number] => 20060165823
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-27
[patent_title] => ' Topical delivery agents and methods for making and using therm'
[patent_app_type] => utility
[patent_app_number] => 11/188129
[patent_app_country] => US
[patent_app_date] => 2005-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 11683
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 49
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0165/20060165823.pdf
[firstpage_image] =>[orig_patent_app_number] => 11188129
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/188129 | Topical delivery agents and methods for making and using therm | Jul 20, 2005 | Abandoned |
Array
(
[id] => 5769169
[patent_doc_number] => 20060019927
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-26
[patent_title] => 'Anti-viral uses of borinic acid complexes'
[patent_app_type] => utility
[patent_app_number] => 11/152959
[patent_app_country] => US
[patent_app_date] => 2005-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14812
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0019/20060019927.pdf
[firstpage_image] =>[orig_patent_app_number] => 11152959
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/152959 | Anti-viral uses of borinic acid complexes | Jun 13, 2005 | Issued |
Array
(
[id] => 6930714
[patent_doc_number] => 20050281748
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-22
[patent_title] => 'Abuse-deterrent drug formulations'
[patent_app_type] => utility
[patent_app_number] => 11/149867
[patent_app_country] => US
[patent_app_date] => 2005-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8046
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0281/20050281748.pdf
[firstpage_image] =>[orig_patent_app_number] => 11149867
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/149867 | Abuse-deterrent drug formulations | Jun 9, 2005 | Issued |
Array
(
[id] => 5125557
[patent_doc_number] => 20070237828
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-11
[patent_title] => 'Ziprasidone Dosage Form'
[patent_app_type] => utility
[patent_app_number] => 11/570392
[patent_app_country] => US
[patent_app_date] => 2005-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3599
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0237/20070237828.pdf
[firstpage_image] =>[orig_patent_app_number] => 11570392
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/570392 | Ziprasidone Dosage Form | Jun 8, 2005 | Abandoned |
Array
(
[id] => 5732271
[patent_doc_number] => 20060257388
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-16
[patent_title] => 'Drug delivery systems for stabilized formulations of alpha adrenergic receptor antagonists and the uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/128184
[patent_app_country] => US
[patent_app_date] => 2005-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 16835
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0257/20060257388.pdf
[firstpage_image] =>[orig_patent_app_number] => 11128184
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/128184 | Drug delivery systems for stabilized formulations of alpha adrenergic receptor antagonists and the uses thereof | May 12, 2005 | Abandoned |